《BioRxiv,3月14日,Dark proteome of Newly Emerged SARS-CoV-2 in Comparison with Human and Bat Coronaviruses》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-15
  • Dark proteome of Newly Emerged SARS-CoV-2 in Comparison with Human and Bat Coronaviruses

    Rajanish Giri, Taniya Bhardwaj, Meenakshi Shegane, Bhuvaneshwari R Gehi, Prateek Kumar, Kundlik Gadhave

    doi: https://doi.org/10.1101/2020.03.13.990598

    Abstract

    Recently emerged Wuhan's novel coronavirus designated as SARS-CoV-2, a causative agent of coronavirus disease 2019 (COVID-19) is rapidly spreading its pathogenicity throughout the world now. More than 4000 mortalities have occurred worldwide till the writing of this article and this number is increasing every passing hour. World Health Organization (WHO) has declared it as a global public health emergency. The multiple sequence alignment data correlated with already published reports on SARS-CoV-2 indicated that it is closely related to Bat-Severe Acute Respiratory Syndrome like coronavirus (Bat CoV SARS-like) and well-studied Human SARS.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.biorxiv.org/content/10.1101/2020.03.13.990598v1
相关报告
  • 《BioRxiv,3月7日,Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-08
    • Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2 Zhiqiang Zheng, Vanessa M. Monteil, Sebastian Maurer-Stroh, Chow Wenn Yew, Carol Leong, Nur Khairiah Mohd-Ismail, Suganya Cheyyatraivendran Arularasu, Vincent Tak Kwong Chow, Raymond Tzer Pin Lin, Ali Mirazimi, Wanjin Hong, Yee-Joo Tan doi: https://doi.org/10.1101/2020.03.06.980037 Abstract The emergence of a novel coronavirus, SARS-CoV-2, at the end of 2019 has resulted in widespread human infections across the globe. While genetically distinct from SARS-CoV, the etiological agent that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003, both coronaviruses exhibit receptor binding domain (RBD) conservation and utilize the same host cell receptor, angiotensin-converting enzyme 2 (ACE2), for virus entry. Therefore, it will be important to test the cross-reactivity of antibodies that have been previously generated against the surface spike (S) glycoprotein of SARS-CoV in order to aid research on the newly emerged SARS-CoV-2. Here, we show that an immunogenic domain in the S2 subunit of SARS-CoV S is highly conserved in multiple strains of SARS-CoV-2. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《BioRxiv,3月2日,Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-03
    • Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13 Longxian Lv, Gaolei Li, Jinhui Chen, Xinle Liang, Yudong Li doi: https://doi.org/10.1101/2020.02.27.969006 Abstract The novel coronavirus SARS-CoV-2 (2019-nCoV) is a member of the family coronaviridae and contains a single-stranded RNA genome with positive-polarity. To reveal the evolution mechanism of SARS-CoV-2 genome, we performed comprehensive genomic analysis with newly sequenced SARS-CoV-2 strains and 20 closely related coronavirus strains. Among 98 nucleotide mutations at 93 sites of the genome among different SARS-CoV-2 strains, 58 of them caused amino acid change, indicating a result of neutral evolution. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.